Table 4.
Effect of CYP2C9 and VKORC1 on mean dose (mg/week), according to genotype and sensitivity group
Gene | Genotype | Mean dose (mg/week) | P-value | |
---|---|---|---|---|
| ||||
VKORCI | GG | 39.33 (mg/week) | 0.0001 | |
AA | 22.95 (mg/week) | |||
CYP2C9 | *l/*l | 33.14 (mg/week) | 0.001 | |
*2/*2 *2/*3 | 20 (mg/week) | |||
| ||||
Sensitivity groups | Mean dose (mg/week) | P-value | Adverse drug reactions | P-value |
| ||||
Normal (n=104) | 35.53 (mg/week) | 0.001 | 35.6% (n=37) | 0.002 |
Moderate (n=44) | 25.21 (mg/week) | 65.9% (n=29) | ||
High (n=4) | 15.6 (mg/week) | 75% (n=3) |